Mutations affecting key components of the JAK-STAT pathway, including the driver mutations JAK2, Calreticulin (CALR), and the myeloproliferative leukemia virus oncogene (MPL), are commonly observed in MPN patients (161, 162). This evidence concerns the gene MPL and myeloproliferative disorder.